v3.26.1
Loans Receivable and ACL-Loans - Schedule of Portfolio Segment and Impairment Methodology, of the ACL-Loan and Related Portfolio (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio $ 72,373   $ 78,933      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 2,887,320   2,761,139      
Loans collectively evaluated for impairment, allowance 30,627   30,705      
Portfolio 2,959,693   2,840,072      
ACL-Loans 30,627 $ 29,580 30,705 $ 29,256 $ 29,485 $ 29,007
Residential Real Estate            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 2,687   2,751      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 25,777   30,388      
Loans collectively evaluated for impairment, allowance 43   55      
Portfolio 28,464   33,139      
ACL-Loans 43 48 55 65 87 94
Commercial Real Estate            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 42,158   35,767      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 1,947,589   1,895,212      
Loans collectively evaluated for impairment, allowance 18,828   20,255      
Portfolio 1,989,747   1,930,979      
ACL-Loans 18,828 18,588 20,255 19,292 20,562 21,838
Construction            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 0   0      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 153,522   153,778      
Loans collectively evaluated for impairment, allowance 2,431   2,251      
Portfolio 153,522   153,778      
ACL-Loans 2,431 1,912 2,251 2,904 2,216 2,059
Commercial Business            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 1,676   1,595      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 714,258   643,726      
Loans collectively evaluated for impairment, allowance 7,663   6,635      
Portfolio 715,934   645,321      
ACL-Loans 7,663 7,706 6,635 5,526 5,244 4,070
Consumer            
Loans individually evaluated for impairment:            
Loans individually evaluated for impairment, portfolio 25,852   38,820      
Loans individually evaluated for impairment, allowance 0   0      
Loans collectively evaluated for impairment:            
Loans collectively evaluated for impairment, portfolio 46,174   38,035      
Loans collectively evaluated for impairment, allowance 1,662   1,509      
Portfolio 72,026   76,855      
ACL-Loans $ 1,662 $ 1,326 $ 1,509 $ 1,469 $ 1,376 $ 946